share_log

Jacobio Pharmaceuticals Doses Non-Small Cell Lung Cancer Patient With Tumor Medication in China Phase 2A Trial

Jacobio Pharmaceuticals Doses Non-Small Cell Lung Cancer Patient With Tumor Medication in China Phase 2A Trial

雅可比奥制药公司在中国肿瘤药物治疗中的剂量非小细胞肺癌患者的2A期试验
MT Newswires ·  2022/08/31 21:02

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发